Directorate Change

RNS Number : 1573S
Dechra Pharmaceuticals PLC
06 September 2010
 



 

 

Issued by Citigate Dewe Rogerson Ltd, Birmingham

Date: Monday, 6 September 2010

 

 

Dechra® Pharmaceuticals PLC ("the Company")

Directorate Change

 

 

Dechra Pharmaceuticals PLC announces that Malcolm Diamond MBE, Non-Executive Director, Senior Independent Director and Chairman of the Remuneration Committee, will be retiring from the Board with effect from 5 November 2010 following over ten years service with the Company.

 

On Malcolm Diamond's retirement, the Board proposes to appoint Neil Warner as Senior Independent Director and Bryan Morton as Chairman of the Remuneration Committee.

 

Michael Redmond, Chairman of Dechra Pharmaceuticals PLC, commented:

 

"On behalf of the Board I would like to extend our gratitude to Malcolm for his valued contribution to the Company over the past ten years.  During this time the Company has grown to be an international veterinary pharmaceutical business and Malcolm has contributed to this with his wide ranging knowledge and experience.  We wish Malcolm and his family all the very best for the future."

 

A replacement will be recruited before the end of the calendar year.

 

 

For further information, please contact:

Zoe Goulding

Company Secretary

01782 771100

 

 

 

Trademarks

Dechra and the Dechra 'D' logo are registered Trademarks of Dechra Pharmaceuticals PLC.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFESASIVIII
UK 100

Latest directors dealings